Alec Stranahan
Stock Analyst at B of A Securities
(0.89)
# 3,046
Out of 4,667 analysts
23
Total ratings
46.15%
Success rate
-28.89%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Alec Stranahan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DAWN Day One Biopharmaceuticals | Upgrades: Buy | $11 → $24 | $13.34 | +79.91% | 3 | Aug 1, 2024 | |
| CATX Perspective Therapeutics | Initiates: Buy | $24 | $3.00 | +700.00% | 1 | Jul 25, 2024 | |
| RVMD Revolution Medicines | Maintains: Buy | $48 → $55 | $56.78 | -3.13% | 3 | Jul 16, 2024 | |
| NVAX Novavax | Maintains: Neutral | $12 → $18 | $8.04 | +123.88% | 3 | Jun 14, 2024 | |
| ERAS Erasca | Downgrades: Neutral | $11 → $6 | $2.60 | +130.77% | 1 | Jan 5, 2024 | |
| KRYS Krystal Biotech | Maintains: Buy | $118 → $140 | $182.29 | -23.20% | 3 | May 25, 2023 | |
| XNCR Xencor | Initiates: Buy | $42 | $24.10 | +74.27% | 1 | May 19, 2023 | |
| YMAB Y-mAbs Therapeutics | Maintains: Neutral | $6 → $12 | $10.10 | +18.81% | 4 | May 15, 2023 | |
| TGTX TG Therapeutics | Maintains: Underperform | $5 → $6 | $34.55 | -82.63% | 2 | Dec 29, 2022 | |
| HOOK HOOKIPA Pharma | Downgrades: Underperform | $60 → $5 | $2.30 | +117.39% | 1 | Dec 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $36.30 | +23.97% | 1 | Dec 1, 2022 |
Day One Biopharmaceuticals
Aug 1, 2024
Upgrades: Buy
Price Target: $11 → $24
Current: $13.34
Upside: +79.91%
Perspective Therapeutics
Jul 25, 2024
Initiates: Buy
Price Target: $24
Current: $3.00
Upside: +700.00%
Revolution Medicines
Jul 16, 2024
Maintains: Buy
Price Target: $48 → $55
Current: $56.78
Upside: -3.13%
Novavax
Jun 14, 2024
Maintains: Neutral
Price Target: $12 → $18
Current: $8.04
Upside: +123.88%
Erasca
Jan 5, 2024
Downgrades: Neutral
Price Target: $11 → $6
Current: $2.60
Upside: +130.77%
Krystal Biotech
May 25, 2023
Maintains: Buy
Price Target: $118 → $140
Current: $182.29
Upside: -23.20%
Xencor
May 19, 2023
Initiates: Buy
Price Target: $42
Current: $24.10
Upside: +74.27%
Y-mAbs Therapeutics
May 15, 2023
Maintains: Neutral
Price Target: $6 → $12
Current: $10.10
Upside: +18.81%
TG Therapeutics
Dec 29, 2022
Maintains: Underperform
Price Target: $5 → $6
Current: $34.55
Upside: -82.63%
HOOKIPA Pharma
Dec 2, 2022
Downgrades: Underperform
Price Target: $60 → $5
Current: $2.30
Upside: +117.39%
Dec 1, 2022
Initiates: Buy
Price Target: $45
Current: $36.30
Upside: +23.97%